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  ABSTRACT 
IN THE POSTOPERATIVE CARDIOTHORACIC SURGICAL PATIENT 
 BEING MECHANICALLY VENTILATED, IS THERE A 
 DIFFERENCE IN OUTCOMES WHEN COMPARING 
 SEDATION WITH DEXMEDETOMIDINE  
VERSUS PROPOFOL? 
by Benjamin Heinrich Riebesel 
December 2016 
Patients undergoing a cardiothoracic operation typically require mechanical 
ventilation in the postoperative phase.  Each year approximately 395,000 of these 
operations are performed in the United States alone.  As many as 10% of these patients 
require reoperation within the first few hours of recovery due to complications (Barash & 
Cullen, 2013).  This comprehensive review of the literature was performed to determine 
whether postoperative sedation with dexmedetomidine leads to better patient outcomes 
than sedation with propofol.  Inclusion criteria included publications written in the 
English language, articles available in full text, articles written within the last 10 years, 
and publications with a focus on a population over the age of 18.  Exclusion criteria 
included articles not written in the English language, articles not available in full text, 
articles not from peer-reviewed journals, and articles focused on pediatric populations.  A 
comprehensive review of the literature was performed and the results from the included 
studies were analyzed regarding patient outcomes in the postoperative cardiothoracic 
surgery patient being mechanically ventilated.  The results of these studies were compiled 
and disseminated via a practice change proposal. 
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CHAPTER I - INTRODUCTION 
Statement of the Problem 
According to the centers for disease control and prevention (CDC) there are 
approximately 395,000 cardiothoracic operations performed annually in the United States 
(US) alone (Centers for Disease Control and Prevention, 2015).  It is estimated that up to 
10 % of these patients experience complications following surgery that necessitate them 
being brought back to the operating room for additional surgery (Barash & Cullen, 2013).  
Examples of complications that can arise are uncontrolled bleeding, graft rupture, aortic 
dissection, cardiac tamponade, myocardial infarction, and poor cardiac performance 
(Barash & Cullen, 2013).  
Patients that have undergone cardiothoracic procedures are brought to the 
intensive care unit (ICU) still intubated and placed on mechanical ventilation until they 
are deemed stable enough to be extubated.  Post-operative mechanical ventilation after 
cardiothoracic surgery can be a stressful event for not only the patient but also the nurse 
caring for the patient.  Sedative agents are commonly used to keep these patients 
comfortable until they can be weaned from mechanical ventilation.  It is the responsibility 
of the healthcare team to ensure that the transition from mechanical ventilation to 
extubation goes as smoothly as possible for the patient. 
In this new era of modern healthcare, advances have been made to reduce patient 
length of stay in the hospital.  As a result, many patients are now placed on “fast track” 
recovery protocols.  The goal of these protocols is to get these patients extubated within 
six hours of being in the ICU (Kiessling et al., 2013).  Having patients remain on 
mechanical ventilation for long periods of time has numerous deleterious effects such as: 
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decrease in patient satisfaction, increased cost to the hospital and the patient, and 
increased incidence of pneumonia.  Since the goal is a rapid recovery, anesthesia 
providers have had to change the way these patients are anesthetized for their operations.  
Newer sedative medications with shorter duration of actions and fewer side effects are 
often being utilized.  It is increasingly common for the anesthesia provider to initiate an 
intravenous sedative infusion in the operating room and have it continued in to the 
postoperative period (Barash & Cullen, 2013). 
Clinical Question 
Because of the increased postoperative risk that cardiothoracic operations bring 
with them, anesthesia providers must carefully tailor all interventions to maximize 
positive patient outcomes.  A clinical question was prepared to establish if the 
administration of dexmedetomidine for postoperative sedation leads to better outcomes 
than utilizing propofol for sedation.  Does the use of dexmedetomidine lead to better 
overall outcomes than with the use of propofol in patients being mechanically ventilated 
following cardiothoracic surgery? 
Purpose of the Project 
The purpose of this capstone project was to assess if overall outcomes improve 
due to the use of dexmedetomidine for sedation of mechanically ventilated patients 
following cardiothoracic surgery when compared to sedation with propofol.  The short 
term goal of this project was to influence a clinical practice change and improve patient 
outcomes at a level II trauma facility in Mississippi.  The long-term goal of this project is 
to improve patient outcomes for anyone undergoing a cardiothoracic operation in the 
United States.
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CHAPTER II - METHODOLOGY 
A comprehensive review of the literature was conducted using electronic 
databases.  The following databases were utilized for this review: Nursing OVID, 
CINAHL, Google Scholar, and PubMed.  Key words that were incorporated into this 
systematic review were: cardiac surgery, dexmedetomidine, cardiovascular surgery, 
cardiothoracic surgery, postoperative, and sedation.  Outcomes from the literature that 
were analyzed included: postoperative time spent on mechanical ventilation, incidence of 
ventilator associated pneumonia, cost effectiveness of dexmedetomidine, and mortality 
and morbidity associated with postoperative sedation.  The outcomes listed above were 
measured in patients who were receiving either dexmedetomidine or propofol for 
postoperative sedation.  Findings from the review of these articles will be assembled and 
used as the basis of a practice change proposal.  This practice change proposal was 
presented to a group of Anesthesiologists at a level II trauma hospital in Mississippi.  The 
intent of this practice change proposal was to attempt to help guide a practice change in 
order to help improve patient outcomes for those patients undergoing cardiothoracic 
surgery. 
Expected Outcomes 
The purpose of this DNP project was to assess whether the use of 
dexmedetomidine or propofol for sedation of postoperative cardiothoracic surgical 
patients led to better outcomes.  The anticipated outcome was to improve patient 
outcomes as a result of a practice change brought about by the formulation, distribution, 
and presentation of a practice change proposal.  This practice change proposal was 
presented to the Anesthesiologists at a level II trauma hospital in Mississippi with the aid 
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of a formal PowerPoint presentation.  After the initial presentation was completed, a short 
questionnaire was given to the Anesthesiologists to assess their willingness to adopt a 
practice change; the practice change proposal was then made available to the department 
with the intent that better patient outcomes would ensue.  
Barriers to Implementation 
A number of barriers were identified during the course of this DNP project.  
There were a limited number of studies performed utilizing dexmedetomidine as a 
sedative agent.  Uncertainty whether the Anesthesiologists at the local level II trauma 
facility would be hesitant to try this newer technique of postoperative sedation was also 
present.  
Target Population 
Articles reviewed for this DNP project included patient populations that were 
over the age of 18, had undergone a cardiothoracic surgery, and were on a mechanical 
ventilator in the postoperative phase.  Cardiothoracic surgery, for the purposes of this 
capstone, includes coronary artery bypass grafting, mitral valve replacement, and aortic 
valve replacement.  Inclusion criteria for articles to be reviewed were: the articles had to 
be published within the last 10 years or be seminal articles, and the articles had to be in 
the English language.  Seminal works are of central importance to a topic; often they are 
the first publications written on a specific topic and offer new insight into an area.  
Exclusion criteria therefore included articles published more than 10 years ago that were 
not seminal articles, and articles published in any language other than English. 
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The Importance of Time Spent on Mechanical Ventilation 
Reducing the amount of time the patients spend on mechanical ventilation greatly 
improves their chance of having a successful, uneventful recovery period.  The mainstay 
of cardiothoracic surgical patient recovery now is the “fast track” route; this route aims to 
have the patient weaned from the mechanical ventilator within six hours (Kiessling et al., 
2013).  Patients on mechanical ventilation for a prolonged period of time are at risk for 
developing ventilator-associated pneumonia (VAP).  Signs and symptoms associated with 
VAP include: (a) temperature greater than 38 degrees Celsius, (b) white blood cell count 
greater than 12,000, (c) new onset purulent drainage from the endotracheal tube, or 
worsening oxygen requirements (Craven & Hjalmarson, 2010).  VAP carries with it a 
nearly 40% mortality rate and an average cost of $40,000 per occurrence (Craven & 
Hjalmarson, 2010). 
Lack of Knowledge regarding Dexmedetomidine 
Dexmedetomidine is a newer sedative agent that was approved for use by the 
Food and Drug Administration (FDA) in 1999.  Because it is a relatively new medication, 
healthcare providers’ knowledge base regarding the drug may not always be vast.  
Dexmedetomidine has a different mechanism of action than most sedative agents and it 
does not depress the respiratory center in the brain (Wanat, Fitousis, Boston, & Masud, 
2014).  Since it does not depress the central respiratory center it does not have to be 
discontinued prior to weaning a patient from the mechanical ventilator, this is a major 
advantage of this medication over conventional sedative agents.  If the patient can be left 
adequately sedated while still being arousable to verbal stimuli, which is the key benefit 
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to using dexmedetomidine, then tracheal extubation can occur in such a way that it is 
comfortable for the patient while still being safe (Karaman et al., 2015). 
Clinical Use of Sedative Agents 
Sedative agents can help facilitate an uneventful transition from mechanical 
ventilation to extubation.  Patients can be kept in a quiescent state until vital signs, 
hemodynamic values, volume status, and postoperative bleeding are all normalized.  
Most institutions use a protocol that contains criteria that help guide the ICU nurse’s 
decision to start weaning the patient from mechanical ventilation.  Some examples of 
criteria that must be met may include the following: fraction of inspired oxygen (Fi02) 
less than 50%, hemodynamically stable, awake and alert, able to maintain airway 
reflexes, negative inspiratory force of 30 cm water, and a rapid shallow breathing index 
(RSBI) of less than 100 (Hensley, Martin, & Gravlee, 2013).  The fraction of inspired 
oxygen is the concentration of oxygen that is set on the ventilator to be delivered to the 
patient; the concentration that is available in the atmosphere is 21%, for the purposes of 
weaning ventilatory support a concentration of 50% or less is desirable (Stoelting & 
Hillier, 2006).  Negative inspiratory force is a test of respiratory muscle strength, during 
spontaneous respiration the diaphragm descends causing a negative pressure within the 
chest that causes air to rush into the lungs.  The negative inspiratory force is simply a way 
to quantify how negative the pressure is that the diaphragmatic movement creates, 30 cm 
of water pressure is an ideal measurement for this test (Barash & Cullen, 2013).  The 
rapid shallow breathing index is a ratio that is used to assess whether the patient is taking 
breaths that are of adequate depth.  The ratio is obtained by dividing the patients breaths 
per minute by their tidal volume, so a patient breathing 25 times per minute with a tidal 
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volume of 250cc would have a RSBI of 100 (Barash & Cullen, 2013).  After these criteria 
have been met the patient can start the process of being weaned from mechanical 
ventilation.  Depending on the type of sedative agent being used, it may or may not have 
to be weaned as well. 
Propofol versus Dexmedetomidine 
Propofol is an isopropylphenol that is administered intravenously in order to 
cause rapid sedation.  Propofol exerts its sedative action via activation of the gamma 
aminobutyric acid (GABA) receptors.  Activation of this receptor causes negatively 
charged chloride ions to hyperpolarize the postsynaptic cell membrane of the neuron and 
therefore inhibit neuronal excitation (Stoelting & Hillier, 2006).  In other words, Propofol 
creates an environment within the neuron that makes it more difficult for the cell to send 
and receive signals.  Propofol is rapidly redistributed to body tissues and the lungs and 
then it is metabolized by the oxidative enzyme cytochrome P-450 (Nagelhout & Plaus, 
2014).  Due to the rapid redistribution of Propofol, patients awaken quickly from a single 
bolus dose therefore a continuous infusion is typically utilized.  This drug works in a 
dose-dependent manner in which a higher dose can be used to provide surgical anesthesia 
or a lower dose can be used for sedation in the intensive care unit (ICU).  Typical doses 
for sedation in the ICU range from 25 to 100 micrograms per kilogram per minute and 
can be delivered via a continuous infusion pump (Stoelting & Hillier, 2006).  Propofol 
produces anesthesia without analgesia and also exhibits a profound respiratory depressant 
effect (Nagelhout & Plaus, 2014). 
Dexmedetomidine is a sedative agent that works by stimulating the presynaptic 
alpha-2 receptor.  Presynaptic alpha-2 receptors work as auto regulatory receptors.  
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Physiologically, norepinephrine normally binds to this receptor and causes a negative 
feedback loop to be initiated.  When the receptor is bound, it signals to the presynaptic 
neuron that the synapse has an adequate concentration of norepinephrine and no more is 
needed.  When the drug dexmedetomidine mimics this effect it results in a decreased 
level of norepinephrine in the synapse and this in turn leads to sedation (Nagelhout & 
Plaus, 2014).  In addition to sedation, other physiologic effects can be seen with 
administration of dexmedetomidine such as hypotension and bradycardia (Barash & 
Cullen, 2013).  Dexmedetomidine is metabolized via glucoronidation in the liver and also 
by the oxidative enzyme cytochrome P-450.  Dexmedetomidine produces sedation at 
doses ranging from 0.2 to 1 microgram per kilogram per hour; a loading dose of 1 
microgram per kilogram can also be used to rapidly achieve an adequate plasma 
concentration.  Dexmedetomidine mainly exerts its actions in the locus ceruleus of the 
brain stem, therefore it does not depress respiration.  One of the main functions of the 
locus ceruleus is the maintenance of the sleep-wake cycle.  Additionally, 
dexmedetomidine exerts some action at the spinal cord level, which is not well 
understood, this accounts for its analgesic properties (Nagelhout & Plaus, 2014). 
Cost Reduction 
Dexmedetomidine use for sedation has been shown to actually decrease that 
patient’s hospital bill by an average of $9679 (Wanat et al., 2014).  The reason for this 
reduction in cost is attributed to a lesser time spent on mechanical ventilation, shortened 
hospital stay, and less adjunct medication use such as morphine.  The use of 
dexmedetomidine has also been shown to decrease incidence of VAP, which can carry 
with it a $40,000 cost increase.  If the figures provided earlier are extrapolated then there 
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are an estimated 39,500 patients at increased risk of contracting VAP; this could possibly 
lead to a cost increase of $1,580,000,000.00 and 15,800 deaths nationwide. 
Research Strategy 
A comprehensive review of the literature was conducted to determine whether 
dexmedetomidine used for sedation of postoperative cardiothoracic surgical patients led 
to better patient outcomes than when the drug propofol was used for the same purpose.  
Once the systematic review is complete and a conclusion is reached, a practice change 
proposal will be made.  The intent of this practice change proposal was to influence a 
practice change and improve patient outcomes at a level II trauma facility in Mississippi. 
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CHAPTER III  - COMPREHENSIVE REVIEW OF THE LITERATURE 
There is a vast amount of literature that has recently been published supporting 
the use of dexmedetomidine for postoperative sedation, specifically for patients that have 
undergone cardiothoracic surgery.  While reviewing the literature a number of barriers to 
the use of dexmedetomidine were identified; they included: (a) concern whether 
dexmedetomidine could reduce postoperative ventilation time without increasing adverse 
events; (b) concern over total cost-effectiveness of dexmedetomidine vs. propofol; (c) 
lack of knowledge regarding advantages and disadvantages of dexmedetomidine for 
sedation.  This review of the literature will seek to determine whether dexmedetomidine 
when used for sedation of postoperative cardiothoracic surgery patients leads to better 
patient outcomes than when sedation with propofol is used. 
Search Methods 
The search of the literature was conducted using the following evidence-based 
databases: CINAHL, Nursing OVID, and Pub Med; in addition to the evidence-based 
databases already mentioned, Google Scholar was also used as a preliminary search 
measure.  Search terms that were utilized included cardiac surgery, dexmedetomidine, 
cardiovascular surgery, cardiothoracic surgery, postoperative, and sedation.  In addition 
to the aforementioned search terms, inclusion criteria consisted of articles in the English 
language, articles available in full text, articles written within the last 10 years, and 
articles that dealt with populations over the age of 18.  Exclusion criteria included articles 
not written in the English language, articles not available in full text, articles not from 
peer-reviewed journals, and articles dealing with pediatric populations.  Patient outcomes 
that were examined in these articles included time spent on mechanical ventilation, 
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incidence of ventilator associated pneumonia, cost effectiveness of dexmedetomidine, 
and mortality and morbidity associated with postoperative mechanical ventilation. 
Dexmedetomidine to reduce Postoperative Ventilation Time  
The length of time spent on mechanical ventilation in the immediate postoperative 
period is crucial.  In years past, cardiothoracic surgical patients in the postoperative 
period would be sedated and left intubated for up to 24 hours while their fluid status, 
hemodynamic parameters, cardiac function, electrolytes, and temperature were being 
normalized (Klineberg, Geer, Hirsh, & Aukburg, 1977).  Hemodynamic parameters that 
are typically monitored in these patients include central venous pressure, pulmonary 
artery pressure, pulmonary capillary wedge pressure, blood pressure, stroke volume, 
cardiac output, and cardiac index (Barash & Cullen, 2013).  It was discovered that 
leaving these patients on the ventilator overnight was not exactly leading to the best 
patient outcomes.  The cardiac surgery community started looking for a better way of 
approaching postoperative care for cardiothoracic surgery patients.  During the period 
from the mid 1970’s to the late 1990’s major advances were made in the intraoperative 
and postoperative care of these patients.  Some of these advances included the utilization 
of transesophageal echocardiography, movement away from use of long acting paralytics 
such as pancuronium, and use of a balanced anesthetic technique instead of a primarily 
narcotic based approach (Stoelting & Hillier, 2006). 
Now the goal in the early postoperative period is to stabilize the patient and wean 
them from the ventilator as quickly as possible (Barash & Cullen, 2013).  The new trend 
in cardiac anesthesia is to “fast-track” cardiothoracic surgical patients.  The goal of fast-
track ventilator weaning is to have the patient extubated within six hours (Karaman et al., 
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2015).  Having these patients extubated within six hours reduces the overall incidence of 
ventilator-associated pneumonia (VAP).  Reducing the incidence of VAP not only 
improves patient outcomes but it has also been shown to improve patient satisfaction 
scores (Craven & Hjalmarson, 2010).  VAP has been shown to be up to 20 times more 
common in mechanically ventilated patients.  It has been associated with a crude 
mortality rate of 20% to 40% and carries with it an average cost of $40,000 per incident 
(Craven & Hjalmarson, 2010). 
A retrospective observational trial was conducted by Wanut and colleagues 
(2014) in which time spent on mechanical ventilation was compared with a group 
receiving dexmedetomidine and a group receiving propofol for postoperative sedation.  
The patients included in this study had undergone coronary artery bypass grafting 
(CABG), mitral valve replacement (MVR), or aortic valve replacement (AVR).  Patients 
were excluded from the study if they were under the age of 18, were pregnant, had a prior 
organ transplant, or were receiving infusions of both dexmedetomidine and propofol.  
There was no randomization to the groups, patients received either dexmedetomidine or 
propofol for sedation based on the ordering physician preference.  The results of the 
study showed that patients that received dexmedetomidine (N=33) had a statistically 
significant reduction in time spent on the ventilator when compared to patients that 
received propofol (N=319), mean ventilation times were 7.4 hours and 12.5 hours 
respectively (p value <.042) (Wanat et al., 2014). 
Karaman et al. (2015) conducted a randomized controlled trial in patients 
undergoing CABG comparing dexmedetomidine to propofol with regard to extubation 
time as well as hemodynamic and respiratory parameters, complication rates, and patient 
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satisfaction scores.  The study included 70 patients and exclusion criteria included 
patients with chronic renal failure, liver failure, congestive heart failure, valvular heart 
disease, respiratory system disorders, propofol or dexmedetomidine allergies, 
Alzheimer’s disease or dementia, ejection fraction of less than 40%, body mass index of 
>30, and a bypass time of >120 minutes.  The patients were randomized to receive either 
dexmedetomidine or propofol for sedation in the postoperative phase.  Dexmedetomidine 
was infused at a rate of 0.2-1.0 micrograms per kilogram per hour and propofol was 
infused at a rate of 1-3 milligrams per kilogram per hour.  The typical infusion rate for 
dexmedetomidine is 0.2-0.7 micrograms per kilogram per hour, and the typical infusion 
rate for Propofol is 1-3 milligrams per kilogram per hour (Nagelhout & Plaus, 2014).  
The study showed that patients that received dexmedetomidine (N=31) had statistically 
significant reductions in ventilator time when compared to patients that received propofol 
(N=33).  Times for the two groups were 266 minutes vs. 323 minutes respectively (p 
value <.001) (Karaman et al., 2015).  The goal of fast track ventilator weaning in these 
patients is 360 minutes (Karaman et al., 2015). 
Park et al. (2014) performed a randomized controlled trial on patients undergoing 
CABG, aortic valvuloplasty (AVP), mitral valvuloplasty (MVP), and combined CABG 
and valve procedures.  In this trial dexmedetomidine was compared to remifentanil with 
regard to neurological, hemodynamic, and sedative differences.  The study included 142 
patients that were randomized into either the dexmedetomidine group or the remifentanil 
group.  Remifentanil is a potent synthetic opioid that is administered via a continuous 
infusion; it is broken down in the plasma by red blood cell esterases and as such it has a 
half-life of approximately four minutes (Nagelhout & Plaus, 2014).  Dexmedetomidine 
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infusion rates were between 0.2-0.8 micrograms per kilogram per hour and remifentanil 
infusion rates were between 1-2.5 milligrams per hour.  The typical dose of remifentanil 
when administered as a continuous infusion is between 0.05-2 milligrams per hour 
(Nagelhout & Plaus, 2014).  The study failed to demonstrate a reduction in postoperative 
ventilation time with dexmedetomidine when compared to remifentanil (p >.05).  
However, the study did conclude that the dexmedetomidine group had a statistically 
significant reduction in overall incidence of postoperative delirium 8.96% compared to 
22.67% (p <.05) (Park et al., 2014).  This study also pointed out that it has been shown 
that a prolonged amount of time on mechanical ventilation can itself lead to increased 
risk of developing delirium by as much as 790% (p <.05) (Park et al., 2014).  
Cost Effectiveness 
Providing patients with cost effective, safe healthcare is in everyone’s best 
interest.  There are a number of studies that have been published elucidating the cost 
effectiveness of using dexmedetomidine for postoperative sedation.  Wanut et al. (2014) 
found in their retrospective observational trial that, on average, using dexmedetomidine 
for postoperative sedation reduced the hospital bill by $9679.00.  This amount of savings 
was due to a combination of things such as: decreased length of time on ventilator, 
decreased incidence of pneumonia and stress ulcers, decreased length of stay in the 
hospital, and less use of adjunct medications such as morphine, beta blockers, and 
epinephrine (Wanat et al., 2014). 
Ji et al. (2013) conducted a single-center, retrospective cohort study that included 
1260 patients that underwent CABG, MVR, or AVR surgery; the aim of their study was 
to determine whether perioperative use of dexmedetomidine reduced the incidence of 
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adverse complications and mortality following surgery.  Exclusion criteria for this study 
included emergency operations, off-pump surgery, robotic surgery, circulatory arrest, and 
surgery involving the thoracic aorta.  The study showed a decrease in the mortality rate 
while in the hospital, 1.23% vs. 4.59% (p < 0.0001).  The study also showed a decrease in 
the 30 day and 1-year mortality rates, 1.76% vs. 5.12% and 3.17% vs. 7.95% respectively 
(p < 0.0001 for both) (Ji et al., 2013).  A perioperative infusion of dexmedetomidine was 
also shown to decrease the overall incidence of complications (stroke, MI, sepsis, cardiac 
arrest, acute renal failure) from 54.06% to 47.18%  (p = 0.0136).  By decreasing the 
likelihood that these patients will experience adverse complications both shortly after 
surgery and even up to one year out from surgery, readmission to the hospital in this time 
period is decreased.  Reimbursement from the Centers for Medicare and Medicaid 
Services (CMS) is now tied to readmission rates (Centers for Medicare and Medicaid 
Services, 2014), so anything that can be proven to reduce these rates is of great benefit to 
an organization and the patient.  
Patients are now being given a survey to fill out upon discharge called the 
Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS), the 
results of this survey factor into reimbursement for the institution (Centers for Medicare 
and Medicaid Services, 2014).  Karaman et al. (2015) found that not only did using 
dexmedetomidine reduce time spent on mechanical ventilation, it also had a statistically 
significant impact of patient satisfaction scores.  The average satisfaction score for the 
dexmedetomidine group was 9 whereas the mean score for the propofol group was 7      
(p value <.001) (Karaman et al., 2015).  
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Knowledge Deficit Regarding Dexmedetomidine 
It was found during this review of the literature that there is a generalizable 
knowledge deficit regarding the advantages to using dexmedetomidine in the 
perioperative setting.  The advantages of dexmedetomidine over conventional sedative 
agents are numerous.  Possibly the most underutilized and unknown benefit of 
dexmedetomidine is that the infusion can be continued for up to 24 hours after extubation 
(Wanat et al., 2014).  Unlike most conventional sedatives that work on the GABA 
receptors, dexmedetomidine exerts its action on the presynaptic alpha-2 adrenergic 
receptors (Nagelhout & Plaus, 2014).  Since its action is mediated through the alpha-2 
receptors, which causes sedation by ultimately reducing the amount of norepinephrine in 
the synaptic cleft and not by mimicking the body’s own sedative mechanism, the 
respiratory center in the brain is not affected.  Because of the unique mechanism of action 
that dexmedetomidine possesses, it can safely be continued in the period following 
tracheal extubation.  
Ren et al. (2013) performed a randomized control trial with the aim of evaluating 
the impact that dexmedetomidine had on myocardial injury in the postoperative period.  
This trial included 162 patients that were undergoing off-pump coronary artery bypass. 
Patients were randomized into two groups, one received dexmedetomidine in the 
perioperative period while the other received propofol.  The study found that using a 
dexmedetomidine in the postoperative period led to a decreased serum level of both 
norepinephrine and cortisol (p < .05).  Norepinephrine and cortisol are both associated 
with an increased stress response that is initiated by surgery or trauma.  In an already 
weakened heart it is important that this stress response be allayed as much as possible.  
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The trial also determined that dexmedetomidine infusions led to a decreased creatinine 
kinase MB isoenzyme (CK-MB) levels (p < .05), and a decreased number of myocardial 
ischemic events (p < .05) (Ren et al., 2013).  Myocardial ischemia ensues when oxygen 
demand by the heart outweighs the oxygen supply from the blood (Barash & Cullen, 
2013)  CK-MB is the isoenzyme of creatinine kinase that is released when myocardial 
cells are irreversibly injured (Kumar et al., 2013). 
In addition to its sedative effects, dexmedetomidine also offers patients some 
analgesic properties.  The analgesic properties of dexmedetomidine are due to its alpha-2 
adrenergic agonist activity at the level of the spinal cord (Barash & Cullen, 2013).  Herr 
et al. (2003) conducted a randomized trial spanning 25 hospitals in the United States and 
Canada investigating differences in analgesic use, beta blocking agents, antiemetic use, 
epinephrine, and diuretics in patients receiving either dexmedetomidine or propofol for 
sedation in the ICU after CABG surgery.  The study consisted of 295 patients that were 
randomized into either the dexmedetomidine group, or the propofol group.  It was found 
that in the dexmedetomidine group, only 28% of patients required morphine for break 
through pain whereas 69% of the patients in the propofol group received morphine (p < 
0.001) (Herr et al., 2003).  It was also shown that the propofol group received, on 
average, four times the amount of morphine that the dexmedetomidine group received 
while in the ICU.  The dexmedetomidine group also received fewer doses of beta 
blockers, antiemetic drugs, epinephrine, and diuretics while in the ICU (Herr et al., 
2003). 
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Doctor of Nursing Practice Essentials 
Doctor of Nursing Practice (DNP) Essential I is the scientific underpinning for 
practice (Zaccagnini & White, 2014).  This essential allows the researcher to integrate the 
science of nursing along with a nursing theory or concept in order to determine a need 
for, and be able to implement a change within a healthcare organization.  Nursing 
theories are classified according to their philosophy, scope, scale, or perspective 
(Zaccagnini & White, 2014).  I plan to utilize a middle range theory into this DNP 
project.  Middle range theories are “specific descriptions, explanations, or predictions 
about a phenomenon of interest” which are narrower in scope than grand theories 
(Zaccagnini & White, 2014, p. 14).  The specific theory that will be incorporated into this 
DNP project is the comfort theory by Katherine Kolcaba.  The comfort theory has a few 
basic assumptions that one must be familiar with in order to apply the theory.  The first 
basic assumption is that people experience holistic responses to complicated situations.  
The second basic assumption is that comfort is indeed a desirable outcome that is 
pertinent to nursing.  Finally, the third basic assumption is that all people will strive to 
have their basic need for comfort met (Kolcaba, 1994).  These three assumptions provide 
the foundation for the comfort theory and give practitioners a vantage point from which 
to view their project.  The use of this theory will help to ascertain whether the use of 
dexmedetomidine leads to increased comfort when compared to propofol. 
DNP Essential II is organizational and systems leadership for quality 
improvement and systems thinking (Zaccagnini & White, 2014).  This essential assists 
the researcher in developing methods to improve healthcare delivery for current and 
future patient populations.  According to this essential, scientific as well as economic 
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findings can be utilized to develop new care delivery approaches.  The aim of this project 
is to determine whether dexmedetomidine leads to better patient outcomes when 
compared to propofol.  The main variable that will determine which of these sedative 
agents leads to better outcomes is the difference in time to extubation between these two 
drugs.  Another variable that will be examined in this capstone is the monetary benefit of 
utilizing one drug over the other.  Both sedative agents provide safe and reliable sedation 
of postoperative cardiothoracic surgery patients; however, it is the aim of this capstone to 
determine which medication produces better patient outcomes and from there a clinical 
practice change will be made with the goal of improving patient safety. 
DNP Essential III is clinical leadership and analytical methods for evidence-based 
practice (Zaccagnini & White, 2014).  This essential helps the researcher to critically 
appraise existing literature and determine what is the best evidence for practice.  This 
capstone project will contain a systematic review of the current literature regarding the 
use of dexmedetomidine for the sedation of postoperative cardiothoracic surgery patients.  
This review of the literature will be synthesized into a practice change proposal and 
presented to a group of local Anesthesiologists in Mississippi with the intent of 
influencing a clinical practice change that will improve patient safety. 
DNP Essential IV is information systems/technology and patient care technology 
for the improvement and transformation of healthcare (Zaccagnini & White, 2014).  This 
essential is of the utmost importance in today’s healthcare field.  Not only is an 
understanding of technology and information systems important when performing actual 
patient care or performing a retrospective chart review, but it is also essential to be able 
to navigate through the electronic databases that contain most of today’s research.  To 
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perform the systematic review of the literature that will be tantamount to the completion 
of this DNP project, multiple electronic sources will need to be navigated in order to find 
the relevant material. 
DNP Essential V is healthcare policy for advocacy in healthcare (Zaccagnini & 
White, 2014).  This essential is important for the researcher since it prepares them to 
develop policies at the institutional, local, state, and federal levels.  It also prepares the 
nursing researcher to educated policy makers regarding safety and patient outcomes. A 
practice change proposal was written and given to a local anesthesia department with the 
hope that it would influence a practice change and improve both patient safety and patient 
outcomes. 
DNP Essential VI interpersonal collaboration for improving patient and 
population health outcomes (Zaccagnini & White, 2014).  This essential is vital to the 
nursing researcher because the DNP prepared nurse must be able to collaborate with 
other professionals in order to establish a meaningful practice change.  Interpersonal 
relationships must be established by the researcher with this capstone project in order to 
influence a change in policy and practice.  Also, the presentation of the practice change 
proposal relied on interpersonal communication between the researcher and the 
Anesthesiologists in order to be effective. 
DNP Essential VII is clinical prevention and population health for improving the 
nation’s health (Zaccagnini & White, 2014).  The DNP prepared nurse must be able to 
analyze scientific data related to their population of interest and synthesize that data into 
meaningful, easy to use information that can be utilized to help implement and evaluate a 
change in practice.  Dexmedetomidine used as a postoperative sedative agent for patients 
 21 
that have undergone a cardiothoracic operation can help reduce time spent on mechanical 
ventilation in this patient population.  By reducing the amount of time spent on 
mechanical ventilation, the incidence of pneumonia is decreased, the patient satisfaction 
levels are increased, cost is decreased to the patient and facility, and there are less 
postoperative myocardial ischemic events.  So by implementing the latest evidence based 
findings with regard to postoperative sedation of cardiothoracic surgery patients, patient 
outcomes can be greatly enhanced. 
DNP Essential VIII is advanced nursing practice (Zaccagnini & White, 2014).  It 
is essential to develop and maintain relationships with other healthcare professionals in 
order to provide better patient care and improve patient outcomes.  Professional 
relationships that are made within the anesthesia department at the local level II trauma 
hospital will be nurtured in order to obtain a lasting, significant practice change at this 
facility.  Also, it is imperative to be able to demonstrate a superior ability to be able to 
evaluate research to ascertain what the best evidence-based practice is.  Within this DNP 
project there is a comprehensive review of the literature that contains the latest research 
on the issue of utilizing dexmedetomidine for sedation of postoperative cardiothoracic 
surgery patients.  At the conclusion of the literature review section it is clear what the 
best evidence for this particular topic is.  With this evidence in hand, a practice change 
proposal was written and given to the local anesthesia department for consideration for 
implementation. 
Practice Change Proposal 
According to the centers for disease control and prevention (CDC) there are 
approximately 395,000 cardiothoracic operations performed annually in the United States 
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alone (Centers for Disease Control and Prevention, 2015).  It is estimated that up to 10% 
of these patients experience complications following surgery that necessitate them being 
brought back to the operating room for additional surgery (Barash & Cullen, 2013).  
Examples of complications that can arise are uncontrolled bleeding, graft rupture, aortic 
dissection, cardiac tamponade, myocardial infarction, and poor cardiac performance 
(Barash & Cullen, 2013). 
These patients are brought from the operating room to the intensive care unit and 
placed on a mechanical ventilator until they are strong enough to be weaned from 
ventilator support.  This period is particularly stressful for the patient as they make the 
transition from being ventilated to maintain their own airway.  The majority of these 
patients require some type of sedation until their hemodynamics stabilize to the point that 
they can start to be weaned from the ventilator.  The typical sedative that is used for 
ventilated patients in the ICU is propofol.   
Propofol is an isopropylphenol that is administered intravenously in order to 
cause rapid sedation.  Propofol exerts its sedative action via activation of the gamma 
aminobutyric acid receptors.  Activation of this receptor causes negatively charged 
chloride ions to hyperpolarize the postsynaptic cell membrane of the neuron and therefore 
inhibit neuronal excitation (Stoelting & Hillier, 2006).  In other words, Propofol creates 
an environment within the neuron that makes it more difficult for the cell to send and 
receive signals.  Propofol is rapidly redistributed to body tissues and the lungs and then it 
is metabolized by the oxidative enzyme cytochrome P-450 (Nagelhout & Plaus, 2014).  
Due to the rapid redistribution of Propofol, patients awaken quickly from a single bolus 
dose therefore a continuous infusion is typically utilized. 
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An alternative drug is also available for sedation of these patients, 
dexmedetomidine.  Dexmedetomidine is a sedative agent that works by stimulating the 
presynaptic alpha-2 receptor.  Presynaptic alpha-2 receptors work as auto regulatory 
receptors.  Physiologically, norepinephrine normally binds to this receptor and causes a 
negative feedback loop to be initiated.  When the receptor is bound, it signals to the 
presynaptic neuron that the synapse has an adequate concentration of norepinephrine and 
no more is needed.  When the drug dexmedetomidine mimics this effect it results in a 
decreased level of norepinephrine in the synapse and this in turn leads to sedation 
(Nagelhout & Plaus, 2014).  In addition to sedation, other physiologic effects can be seen 
with administration of dexmedetomidine such as hypotension and bradycardia (Barash & 
Cullen, 2013).  Dexmedetomidine is metabolized via glucoronidation in the liver and also 
by the oxidative enzyme cytochrome P-450.  Dexmedetomidine produces sedation at 
doses ranging from 0.2 to 1 microgram per kilogram per hour; a loading dose of 1 
microgram per kilogram can also be used to rapidly achieve an adequate plasma 
concentration.  Dexmedetomidine mainly exerts its actions in the locus ceruleus of the 
brainstem, therefore it does not depress respiration.  One of the main functions of the 
locus ceruleus is the maintenance of the sleep-wake cycle.  Additionally, 
dexmedetomidine exerts some action at the spinal cord level, which is not well 
understood, this accounts for its analgesic properties (Nagelhout & Plaus, 2014). 
The purpose of this DNP project was to determine whether sedation with 
dexmedetomidine leads to better patient outcomes when compared to sedation with 
propofol.  A comprehensive review of the literature was performed and outcomes were 
compared between propofol and dexmedetomidine.  The results of the literature review 
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were taken to a level II trauma center in Mississippi and discussed with the staff 
Anesthesiologists there.  The Anesthesiologists were given a short questionnaire 
inquiring whether or not they would be willing to change their practice based on the 
current literature.  Eighty percent (4/5) of the Anesthesiologists that were presented with 
this information said that they would consider a practice change, the only one that did not 
say yes instead said “maybe”. 
Some findings from the review of the literature are as follows.  Dexmedetomidine 
use was found to lead to a shorter duration of time spent on mechanical ventilation when 
compared to propofol (Wanat et al., 2014).  Patients who spend less time on the ventilator 
are less susceptible to acquiring VAP, which carries with it a 40% crude mortality rate 
(Craven & Hjalmarson, 2010).  The use of dexmedetomidine was proven to reduce the 
overall hospital bill by approximately $9679 (Wanat et al., 2014); this was due to a 
number of variables such as decreased time spent on mechanical ventilation, decreased 
length of stay in ICU and decrease in adjunct medication given (morphine, epinephrine, 
beta blockers).  In hospital, 30 day, and 1 year mortality rates were also all proven to be 
lower in the dexmedetomidine patients (Ji et al., 2013). 
Based on the information gleaned from the review of the literature and compiled 
within this DNP project, dexmedetomidine is a superior sedative agent when compared to 
propofol for postoperative sedation of cardiothoracic surgery patients.  The 
recommendation of this capstone project is that dexmedetomidine be used for sedation in 
this patient population.  Furthermore, is it also recommended that the changes proposed 
within this capstone project be tested for accuracy to determine whether a real world 
practice change should take place. 
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CHAPTER IV – SUMMARY 
The goal of this DNP project was to determine whether sedation with 
dexmedetomidine leads to better outcomes when compared to sedation with propofol in 
the postoperative cardiothoracic surgical patient population.  Outcomes in several areas 
were focused on when the review of the literature was conducted.  These areas included: 
postoperative time spent on mechanical ventilation, incidence of VAP, cost effectiveness 
of dexmedetomidine, and mortality and morbidity associated with postoperative sedation.    
A comprehensive review of the literature was conducted and the results from 
these randomized controlled trials and retrospective studies were compiled within this 
capstone project.  These results were then presented to the staff Anesthesiologists at a 
level II trauma hospital in Mississippi with a subsequent survey on whether or not they 
would consider a practice change based upon the evidence from the literature. 
Summary of Findings 
The most influential finding of this systematic review of the literature was that the 
use of dexmedetomidine lead to a decreased amount of time spent on mechanical 
ventilation.  Due to the reduced amount of time spent on the ventilator the patients’ risk 
of acquiring VAP were also reduced; VAP carries with it a 40% mortality rate and a cost 
of up to $40,000.  This literature review also showed that the patients receiving 
dexmedetomidine were discharged from the intensive care unit faster and required 
significantly less pain medication. 
The use of dexmedetomidine for postoperative sedation of cardiothoracic surgical 
patients was also shown to decrease mortality rates.  The in-hospital mortality rate 
decreased from 4.59% to 1.23%, the 30-day and 1-year mortality rates both also 
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decreased by a significant amount (5.12% to 1.76% and 7.95% to 3.17% respectively).  
Lastly, the cost effectiveness of utilizing dexmedetomidine was analyzed.  One study 
found that patients receiving dexmedetomidine postoperatively had a reduction in their 
hospital bills by an average of $9679.  This cost reduction was attributed to less time 
spent on mechanical ventilation, less time in the ICU and fewer adjunct medications 
administered. 
Following the completion of the review of the literature and after IRB approval 
was obtained, the results of this literature review were presented to the staff 
Anesthesiologists at a local level II trauma facility.  Of the 5 Anesthesiologists that were 
presented with these results, 4 of them stated that they would consider a practice change 
and the other one stated “maybe” when asked about a practice change.   
Recommendations 
This review of the literature showed that the use of dexmedetomidine for sedation 
of postoperative cardiothoracic surgical patients leads to better patient outcomes and 
overall decreased cost to the patient.  The next step in the process of implementing this 
practice change proposal will be to get surgeon approval; without their help this proposal 
will not be successful.  The recommendation of this DNP project is that someone take 
this literature review a step further and present these results to the cardiothoracic 
surgeons at the level II trauma hospital in Mississippi.  The results of this capstone 
project should then be tested to determine if the results are significant enough to warrant 
a clinical practice change. 
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Conclusion 
The aim of this DNP project was to determine whether sedation with 
dexmedetomidine lead to better patient outcomes when compared with propofol sedation. 
The ultimate desire is to influence a practice change based upon the evidence discovered 
in the literature. It is my sincere belief that the results found within this DNP project and 
the practice change proposal will help clinicians make better decisions regarding sedation 
for their patients and ultimately will improve patient outcomes.  
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